A retrospective single-center study found that adding low-dose dexmedetomidine to ciprofol was associated with fewer ...
A randomized controlled trial found that adding dexmedetomidine to a ropivacaine erector spinae plane block did not reduce ...
Medetomidine is complicating withdrawal from illicit drugs, leaving people struggling to find treatment that can help them ...
Stem cell protocols at Healthi Life are given only after a medical consultation and on a physician's prescription. Individual responses vary. This article is for general information and is not medical ...
Series: "Delirium and Sleep Rhythms" #12Key Points of This IssueIn the previous meta-analysis, it was dexmedetomidine that ...
Series: "Delirium and Sleep Rhythms" #11Key Points of This IssueChapter 3 discusses preventive interventions. Does regulating ...
Teva stock is in focus after the company acquired a late-stage neuroscience candidate under FDA review. BXCL501 could bring acute agitation treatment into the home. Teva completed the purchase of ...
Teva Pharmaceutical Industries (ISIN US8816242098) completed its acquisition of worldwide rights to BXCL501 on October 27, 2026, adding a late-stage neuroscience asset under FDA review. The ...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed the acquisition of neuroscience assets from BioXcel Therapeutics, Inc., including worldwide rights to BXCL501, a dexmedetomidine ...
BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults ...